Dexamethasone is a fluorinated glucocorticoid medication used to treat rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive pulmonary disease (COPD), croup, brain swelling, eye pain following eye surgery, superior v + some more technical info. It is a potent synthetic corticosteroid with the molecular formula C22H29FO5, high glucocorticoid receptor affinity and minimal mineralocorticoid activity, producing anti-inflammatory and immunosuppressive effects primarily via modulation of gene transcription, induction of annexin A1, and suppression of pro-inflammatory cytokine and eicosanoid synthesis. Clinically available as oral, intravenous, intramuscular and topical formulations, dexamethasone has a short plasma elimination half-life of about 3 to 5 hours and a prolonged biological effect with a duration of action of approximately 36 to 72 hours; dose adjustments are guided by indication, route, comorbidities and concurrent therapies.

Parent: Dexamethasone

Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone/ Betamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone / Dexamethasone Acetate
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone / Betamethasone
Parent: Dexamethasone / Mometasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone
Parent: Dexamethasone / Dexamethasone Isonicotinate
Parent: Dexamethasone
Parent: Dexamethasone
Typical quality specifications control known related compounds and process- or degradation-related impurities such as epimeric forms, 21-hydroxy and 6-hydroxy derivatives, des-fluoro and de-methyl analogs, esterified derivatives and residual solvents; analytical methods used include HPLC with UV or MS detection, and forced-degradation studies define degradants. Typical specification limits follow ICH and pharmacopeial practice with individual unspecified related substances usually limited to 0.1 to 0.2 percent by weight and total impurities commonly limited to 0.5 to 1.0 percent by weight depending on the monograph and product, while known specified impurities may have individual limits set by safety and toxicology data; final release also requires assay within the stated potency range and compliance with residual solvent and microbial limits.
Dexamethasone is used to reduce inflammation and suppress immune responses across a range of conditions including rheumatologic disorders, severe allergic reactions, asthma exacerbations and COPD flares, laryngeal croup, cerebral edema, specific ophthalmic inflammatory states and as part of certain oncology protocols; choice of dose and route depends on the indication and patient factors.
No, dexamethasone is not a sleeping tablet; it is a corticosteroid and can in some patients cause insomnia, mood changes or agitation rather than sedation, so it is not used to induce sleep.
Yes, dexamethasone is a potent glucocorticoid with greater anti-inflammatory potency than prednisone or hydrocortisone and minimal mineralocorticoid effect, which is why dosing and duration require careful clinical oversight to manage therapeutic benefits and potential adverse effects.